Spacelabs Healthcare Qube Compact Monitor, Model 91390. Intended to alert the user to alarm co...
FDA Device Recall #Z-1852-2014 — Class II — June 6, 2014
Recall Summary
| Recall Number | Z-1852-2014 |
| Classification | Class II — Moderate risk |
| Date Initiated | June 6, 2014 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Spacelabs Healthcare Inc |
| Location | Snoqualmie, WA |
| Product Type | Devices |
| Quantity | 3383 in the USA; 1459 outside the USA |
Product Description
Spacelabs Healthcare Qube Compact Monitor, Model 91390. Intended to alert the user to alarm conditions that are reported by Spacelabs Healthcare parameter modules and/or other physiologic monitors via Flexport interfaces.
Reason for Recall
Spacelabs Healthcare is recalling Qube Compact Monitor, Model 91390, due to a potential chance of losing network connection after switching from hardwired Ethernet connection to using the Qube Docking Station without powering down the device. The bedside monitor and all of its alarms will continue to function normally. No one has been injured as a result of this issue.
Distribution Pattern
Worldwide Distribution -- USA, including the states of AL, AZ, CA, CO, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, ME, MI, MN, MO, MS, MT, NC, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, VA, WA, WI, and WY; and, the countries of AFG,ARE, ARG, AUS, BHR, BOL, CAN, CHE, CHL, CHN, COL, CRI, DEU, DOM, ECU, FRA, GBR, IND, ITA, JOR, KWT, LBY, MYS, NLD, OMN, PAN, POL, PRT, ROU, SAU, SGP, THA, TTO, TUN, TUR, TWN, and VNM.
Lot / Code Information
n/a
Other Recalls from Spacelabs Healthcare Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0532-2018 | Class II | Spacelabs Healthcare Xhibit Telemetry Receiver,... | Jan 17, 2018 |
| Z-0332-2017 | Class II | Xhibit Central Station, Model 96102. Inten... | Oct 18, 2016 |
| Z-2885-2016 | Class II | Spacelabs Healthcare Xhibit Central Station, Mo... | Aug 25, 2016 |
| Z-2886-2016 | Class II | Spacelabs Healthcare Xhibit Telemetry Receiver ... | Aug 25, 2016 |
| Z-2343-2016 | Class II | 91496 Ultraview SL Command Module, Options A, B... | Jul 1, 2016 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.